Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07124702 · ClinicalTrials.gov registry record · NA

Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy

A NA study of Gestational Weight Gain and Dual Use of Cigarettes and E-cigarettes, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT07124702 is a NA study of Gestational Weight Gain and Dual Use of Cigarettes and E-cigarettes that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 45 participants, below the 487-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07124702, a NA study of Gestational Weight Gain and Dual Use of Cigarettes and E-cigarettes, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

We propose a randomized controlled trial to develop and evaluate a cessation program with two different strategies for dual users during pregnancy. We plan to enroll 45 pregnant mothers (≤20 gestational weeks) with low household incomes from the Western NY region. To be eligible, they must be currently dual using CCs and nicotine-containing ECs. These mothers will be randomized into one of three groups: 1) simultaneous cessation intervention group (N=15), 2) stepwise cessation intervention group (N=15), and 3) control group (N=15). We hypothesize that nicotine abstinence rates at 8 weeks after randomization will be higher in the intervention groups than in the control group.

Conditions Studied

Gestational Weight Gain Dual Use of Cigarettes and E-cigarettes Birth-weight-for-gestational-age z Score

Interventions

  • BEHAVIORAL Simultaneous cessation intervention
  • BEHAVIORAL Stepwise cessation intervention
  • BEHAVIORAL Behavior counseling only

Study Locations (1)

New York

  • State University of New York at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-10-01
Est. Completion 2027-03-31
Phase NA

Sponsor

State University of New York at Buffalo

243 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07124702

The ClinicalTrials.gov registry entry for NCT07124702 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 487-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (91% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gestational Weight Gain appearing as the primary indexed condition, and to 3 interventions - of which Simultaneous cessation intervention is the first listed.

NCT07124702 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07124702 about?

NCT07124702 is a clinical study titled "Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy". We propose a randomized controlled trial to develop and evaluate a cessation program with two different strategies for dual users during pregnancy. We plan to enroll 45 pregnant mothers (≤20 gestational weeks) with low household incomes from the Western NY region. To be eligible, they must be curren...

What is the current status of trial NCT07124702?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-10-01. Estimated completion is 2027-03-31.

What conditions does trial NCT07124702 study?

This clinical trial studies the following conditions: Gestational Weight Gain, Dual Use of Cigarettes and E-cigarettes, Birth-weight-for-gestational-age z Score.

What interventions are being tested in trial NCT07124702?

The interventions under investigation include: Simultaneous cessation intervention (BEHAVIORAL), Stepwise cessation intervention (BEHAVIORAL), Behavior counseling only (BEHAVIORAL).

Who is sponsoring clinical trial NCT07124702?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07124702 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gestational Weight Gain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gestational Weight Gain

All registered trials for this condition

Dual Use of Cigarettes and E-cigarettes

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.